These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

281 related articles for article (PubMed ID: 9103399)

  • 21. Increase of doxorubicin-induced apoptosis after knock-down of gonadotropin-releasing hormone receptor expression in human endometrial, ovarian and breast cancer cells.
    Fister S; Schlotawa L; Günthert AR; Emons G; Gründker C
    Gynecol Endocrinol; 2008 Jan; 24(1):24-9. PubMed ID: 17943530
    [TBL] [Abstract][Full Text] [Related]  

  • 22. Endometrial hyperplasia involving endometrial polyps: report of a series and discussion of the significance in an endometrial biopsy specimen.
    Kelly P; Dobbs SP; McCluggage WG
    BJOG; 2007 Aug; 114(8):944-50. PubMed ID: 17565613
    [TBL] [Abstract][Full Text] [Related]  

  • 23. [Morphometric and histological evaluation of uterine leiomyomas treated with GnRH agonists or progestational agents].
    Resta L; Sanguedolce F; Orsini G; Laricchia L; Piscitelli D; Fiore MG
    Pathologica; 2004 Apr; 96(2):35-41. PubMed ID: 15449444
    [TBL] [Abstract][Full Text] [Related]  

  • 24. Gonadotropin-releasing hormone agonist reduces aromatase cytochrome P450 and cyclooxygenase-2 in ovarian endometrioma and eutopic endometrium of patients with endometriosis.
    Kim YA; Kim MR; Lee JH; Kim JY; Hwang KJ; Kim HS; Lee ES
    Gynecol Obstet Invest; 2009; 68(2):73-81. PubMed ID: 19401614
    [TBL] [Abstract][Full Text] [Related]  

  • 25. Morphologic patterns of human endometrial epithelium in women with uterine myomata treated with leuprorelin acetate.
    Palmara V; Triolo O; Benedetto V; Lo Re C; Sturlese E; Retto G; Santoro G
    Gynecol Obstet Invest; 2010; 69(2):131-5. PubMed ID: 19996602
    [TBL] [Abstract][Full Text] [Related]  

  • 26. Gonadotropin-releasing hormone agonists and laparoscopy in the treatment of adenomyosis with infertility.
    Lin J; Sun C; Zheng H
    Chin Med J (Engl); 2000 May; 113(5):442-5. PubMed ID: 11776101
    [TBL] [Abstract][Full Text] [Related]  

  • 27. Flow cytometrical DNA measurements in endometrial hyperplasias. A prospective follow-up study after abrasio only or additional high-dose gestagen treatment.
    Lindahl B; Alm P
    Anticancer Res; 1991; 11(1):391-5. PubMed ID: 1826822
    [TBL] [Abstract][Full Text] [Related]  

  • 28. Regression of endometrial hyperplasia after treatment with the gonadotrophin-releasing hormone analogue triptorelin: a prospective study.
    Grimbizis G; Tsalikis T; Tzioufa V; Kasapis M; Mantalenakis S
    Hum Reprod; 1999 Feb; 14(2):479-84. PubMed ID: 10099998
    [TBL] [Abstract][Full Text] [Related]  

  • 29. Resectoscopic surgery may be an alternative to hysterectomy in high-risk women with atypical endometrial hyperplasia.
    Edris F; Vilos GA; Al-Mubarak A; Ettler HC; Hollett-Caines J; Abu-Rafea B
    J Minim Invasive Gynecol; 2007; 14(1):68-73. PubMed ID: 17218233
    [TBL] [Abstract][Full Text] [Related]  

  • 30. Clinical and pathological responses of progestin therapy for non-atypical endometrial hyperplasia: a prospective study.
    Rattanachaiyanont M; Angsuwathana S; Techatrisak K; Tanmahasamut P; Indhavivadhana S; Leerasiri P
    J Obstet Gynaecol Res; 2005 Apr; 31(2):98-106. PubMed ID: 15771634
    [TBL] [Abstract][Full Text] [Related]  

  • 31. Apoptosis may be an early event of progestin therapy for endometrial hyperplasia.
    Amezcua CA; Lu JJ; Felix JC; Stanczyk FZ; Zheng W
    Gynecol Oncol; 2000 Nov; 79(2):169-76. PubMed ID: 11063639
    [TBL] [Abstract][Full Text] [Related]  

  • 32. [Atypical adenomatous hyperplasia of the endometrium].
    Latin V; Krzisnik Z
    Jugosl Ginekol Opstet; 1979; 19(1-2):1-9. PubMed ID: 550012
    [TBL] [Abstract][Full Text] [Related]  

  • 33. Gonadotropin-releasing hormone agonist blocks anxiogenic-like and depressant-like effect of corticotrophin-releasing hormone in mice.
    Umathe SN; Bhutada PS; Jain NS; Shukla NR; Mundhada YR; Dixit PV
    Neuropeptides; 2008 Aug; 42(4):399-410. PubMed ID: 18533256
    [TBL] [Abstract][Full Text] [Related]  

  • 34. Increased natural killer cells and decreased regulatory T cells are seen in complex atypical endometrial hyperplasia and well-differentiated carcinoma treated with progestins.
    Witkiewicz AK; McConnell T; Potoczek M; Emmons RV; Kurman RJ
    Hum Pathol; 2010 Jan; 41(1):26-32. PubMed ID: 19733383
    [TBL] [Abstract][Full Text] [Related]  

  • 35. Effects of central administration of gonadotropin-releasing hormone agonists and antagonist on elevated plus-maze and social interaction behavior in rats.
    Umathe SN; Bhutada PS; Jain NS; Dixit PV; Wanjari MM
    Behav Pharmacol; 2008 Jul; 19(4):308-16. PubMed ID: 18622178
    [TBL] [Abstract][Full Text] [Related]  

  • 36. Management of patients with non-atypical and atypical endometrial hyperplasia with a levonorgestrel-releasing intrauterine system: long-term follow-up.
    Wildemeersch D; Janssens D; Pylyser K; De Wever N; Verbeeck G; Dhont M; Tjalma W
    Maturitas; 2007 Jun; 57(2):210-3. PubMed ID: 17270370
    [TBL] [Abstract][Full Text] [Related]  

  • 37. Cell growth effects of leuprolide on cultured endometrioma cells.
    Levine D; Kaufman L; Cuenca VG; Badawy SZ
    J Reprod Med; 2007 Jul; 52(7):581-4. PubMed ID: 17847754
    [TBL] [Abstract][Full Text] [Related]  

  • 38. Do all girls with apparent idiopathic precocious puberty require gonadotropin-releasing hormone agonist treatment?
    Léger J; Reynaud R; Czernichow P
    J Pediatr; 2000 Dec; 137(6):819-25. PubMed ID: 11113839
    [TBL] [Abstract][Full Text] [Related]  

  • 39. [Atypical hyperplasia and complex hyperplasia of endometrium in women of reproductive age].
    Guo LN
    Zhonghua Fu Chan Ke Za Zhi; 1993 Dec; 28(12):725-7, 760. PubMed ID: 8137643
    [TBL] [Abstract][Full Text] [Related]  

  • 40. [Immunohistochemical study of the expression of receptors to steroid hormones in endometrial hyperplastic processes].
    Lysenko ON; Ashkhab MKh; Strizhova NV; Babichenko II
    Arkh Patol; 2004; 66(2):7-10. PubMed ID: 15154374
    [TBL] [Abstract][Full Text] [Related]  

    [Previous]   [Next]    [New Search]
    of 15.